Literature DB >> 26204972

The potential of L-shell X-ray fluorescence CT (XFCT) for molecular imaging.

Magdalena Bazalova-Carter1,2.   

Abstract

X-ray fluorescence CT (XFCT), a novel modality proposed for high-sensitivity high-resolution molecular imaging of probes labelled with a high atomic-number element, has been performed with high-energy K-shell X-rays. XFCT performed with low-energy L-shell X-rays could, in principle, result in an increase of XFCT imaging sensitivity; however, the significant L-shell X-ray attenuation limits its use for imaging of small objects. This commentary discusses the advantages and drawbacks of L-shell XFCT imaging.

Entities:  

Mesh:

Year:  2015        PMID: 26204972      PMCID: PMC4743439          DOI: 10.1259/bjr.20140308

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  18 in total

1.  Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer.

Authors:  Ivan H El-Sayed; Xiaohua Huang; Mostafa A El-Sayed
Journal:  Nano Lett       Date:  2005-05       Impact factor: 11.189

2.  Material differentiation by dual energy CT: initial experience.

Authors:  Thorsten R C Johnson; Bernhard Krauss; Martin Sedlmair; Michael Grasruck; Herbert Bruder; Dominik Morhard; Christian Fink; Sabine Weckbach; Miriam Lenhard; Bernhard Schmidt; Thomas Flohr; Maximilian F Reiser; Christoph R Becker
Journal:  Eur Radiol       Date:  2006-12-07       Impact factor: 5.315

3.  Computed tomography for imaging the breast.

Authors:  John M Boone; Alex L C Kwan; Kai Yang; George W Burkett; Karen K Lindfors; Thomas R Nelson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-04       Impact factor: 2.673

4.  Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside.

Authors:  R C Urtasun; M B Parliament; A J McEwan; J R Mercer; R H Mannan; L I Wiebe; C Morin; J D Chapman
Journal:  Br J Cancer Suppl       Date:  1996-07

5.  Brain tumors: MR imaging with gadolinium-DTPA.

Authors:  R Felix; W Schörner; M Laniado; H P Niendorf; C Claussen; W Fiegler; U Speck
Journal:  Radiology       Date:  1985-09       Impact factor: 11.105

6.  X-ray fluorescent CT imaging of cerebral uptake of stable-iodine perfusion agent iodoamphetamine analog IMP in mice.

Authors:  Tohoru Takeda; Jin Wu; Qingkai Huo; Tetsuya Yuasa; Kazuyuki Hyodo; F Avraham Dilmanian; Takao Akatsuka
Journal:  J Synchrotron Radiat       Date:  2008-11-21       Impact factor: 2.616

7.  Gold nanoparticles: a new X-ray contrast agent.

Authors:  J F Hainfeld; D N Slatkin; T M Focella; H M Smilowitz
Journal:  Br J Radiol       Date:  2006-03       Impact factor: 3.039

8.  Targeted gold nanoparticles enable molecular CT imaging of cancer.

Authors:  Rachela Popovtzer; Ashish Agrawal; Nicholas A Kotov; Aron Popovtzer; James Balter; Thomas E Carey; Raoul Kopelman
Journal:  Nano Lett       Date:  2008-12       Impact factor: 11.189

9.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.

Authors:  D H Miller; P Rudge; G Johnson; B E Kendall; D G Macmanus; I F Moseley; D Barnes; W I McDonald
Journal:  Brain       Date:  1988-08       Impact factor: 13.501

10.  Vasoactive intestinal peptide receptor scintigraphy.

Authors:  I Virgolini; A Kurtaran; M Raderer; M Leimer; P Angelberger; E Havlik; S Li; W Scheithauer; B Niederle; P Valent
Journal:  J Nucl Med       Date:  1995-10       Impact factor: 10.057

View more
  2 in total

1.  Quantitative X-ray fluorescence imaging of gold nanoparticles using joint L1 and total variation regularized reconstruction.

Authors:  Junwei Shi; Blaine Granger; Keying Xu; Yidong Yang
Journal:  Quant Imaging Med Surg       Date:  2020-01

2.  Pinhole X-ray fluorescence imaging of gadolinium and gold nanoparticles using polychromatic X-rays: a Monte Carlo study.

Authors:  Seongmoon Jung; Wonmo Sung; Sung-Joon Ye
Journal:  Int J Nanomedicine       Date:  2017-08-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.